Magnetar Financial LLC Sells 24,168 Shares of Danaher Corporation $DHR

Magnetar Financial LLC cut its position in Danaher Corporation (NYSE:DHR) by 87.5% in the second quarter, according to its most recent Form 13F filing with the SEC. The institutional investor owned 3,439 shares of the conglomerate’s stock after selling 24,168 shares during the quarter. Magnetar Financial LLC’s holdings in Danaher were worth $679,000 at the end of the most recent reporting period.

A number of other institutional investors have also modified their holdings of the company. Pacific Capital Partners Ltd acquired a new position in shares of Danaher during the first quarter worth $7,175,000. Mediolanum International Funds Ltd increased its position in Danaher by 41.4% during the 1st quarter. Mediolanum International Funds Ltd now owns 22,459 shares of the conglomerate’s stock valued at $4,623,000 after buying an additional 6,574 shares in the last quarter. LPL Financial LLC raised its stake in Danaher by 2.6% in the first quarter. LPL Financial LLC now owns 412,751 shares of the conglomerate’s stock valued at $84,614,000 after buying an additional 10,507 shares during the last quarter. Werba Rubin Papier Wealth Management raised its stake in Danaher by 5.8% in the first quarter. Werba Rubin Papier Wealth Management now owns 1,340 shares of the conglomerate’s stock valued at $275,000 after buying an additional 73 shares during the last quarter. Finally, Schubert & Co boosted its holdings in Danaher by 0.3% in the first quarter. Schubert & Co now owns 39,648 shares of the conglomerate’s stock worth $8,128,000 after acquiring an additional 118 shares in the last quarter. 79.05% of the stock is currently owned by institutional investors.

Danaher Price Performance

Shares of DHR opened at $227.05 on Tuesday. The business’s 50-day moving average is $209.36 and its two-hundred day moving average is $202.34. The company has a market capitalization of $160.38 billion, a P/E ratio of 46.81, a P/E/G ratio of 3.28 and a beta of 0.81. Danaher Corporation has a fifty-two week low of $171.00 and a fifty-two week high of $258.23. The company has a debt-to-equity ratio of 0.33, a quick ratio of 1.10 and a current ratio of 1.52.

Danaher (NYSE:DHR) last issued its earnings results on Monday, October 20th. The conglomerate reported $1.89 EPS for the quarter, topping analysts’ consensus estimates of $1.72 by $0.17. The firm had revenue of $6.05 billion for the quarter, compared to the consensus estimate of $6 billion. Danaher had a return on equity of 10.92% and a net margin of 14.44%.The company’s revenue was up 4.4% compared to the same quarter last year. During the same quarter in the prior year, the business earned $1.71 earnings per share. Research analysts predict that Danaher Corporation will post 7.63 earnings per share for the current year.

Danaher Announces Dividend

The company also recently announced a quarterly dividend, which was paid on Friday, October 31st. Stockholders of record on Friday, September 26th were issued a dividend of $0.32 per share. This represents a $1.28 annualized dividend and a dividend yield of 0.6%. The ex-dividend date of this dividend was Friday, September 26th. Danaher’s payout ratio is 26.39%.

Insider Activity at Danaher

In related news, SVP Georgeann Couchara sold 5,174 shares of the stock in a transaction on Monday, November 10th. The shares were sold at an average price of $210.42, for a total transaction of $1,088,713.08. Following the sale, the senior vice president directly owned 2,625 shares of the company’s stock, valued at approximately $552,352.50. This represents a 66.34% decrease in their ownership of the stock. The sale was disclosed in a filing with the SEC, which is available at this hyperlink. Also, Director Teri List sold 3,298 shares of the firm’s stock in a transaction on Tuesday, November 18th. The shares were sold at an average price of $226.50, for a total transaction of $746,997.00. Following the sale, the director owned 20,762 shares in the company, valued at approximately $4,702,593. This represents a 13.71% decrease in their position. Additional details regarding this sale are available in the official SEC disclosure. Insiders sold a total of 30,248 shares of company stock worth $6,609,663 in the last three months. Company insiders own 11.10% of the company’s stock.

Analyst Upgrades and Downgrades

A number of analysts recently commented on DHR shares. Robert W. Baird set a $247.00 target price on shares of Danaher in a research note on Wednesday, October 22nd. Wall Street Zen raised shares of Danaher from a “hold” rating to a “buy” rating in a report on Saturday. Royal Bank Of Canada set a $241.00 target price on Danaher in a research report on Tuesday, September 2nd. Wells Fargo & Company reiterated a “positive” rating on shares of Danaher in a research note on Thursday, October 23rd. Finally, Cowen restated a “buy” rating on shares of Danaher in a research note on Wednesday, October 22nd. Eighteen equities research analysts have rated the stock with a Buy rating and five have assigned a Hold rating to the company. Based on data from MarketBeat, the company has an average rating of “Moderate Buy” and a consensus target price of $243.39.

Danaher Profile

Danaher Corporation designs, manufactures, and markets professional, medical, industrial, and commercial products and services worldwide. The Biotechnology segments offers bioprocess technologies, consumables, and services that advance, accelerate, and integrate the development and manufacture of therapeutics; cell line and cell culture media development services; cell culture media, process liquids and buffers for manufacturing, chromatography resins, filtration technologies, aseptic fill finish; single-use hardware and consumables and services, such as the design and installation of full manufacturing suites; lab filtration, separation, and purification; lab-scale protein purification and analytical tools; reagents, membranes, and services; and healthcare filtration solutions.